Log in
Enquire now
GeneOne Life Science

GeneOne Life Science

GeneOne Life Science is a South Korea-based company specializing in vaccine and immunotherapy development.

OverviewStructured DataIssuesContributors

Contents

genels.com
Is a
Organization
Organization
Company
Company

Company attributes

Industry
Healthcare
Healthcare
Vaccine
Vaccine
0
Biopharmaceutical
Biopharmaceutical
Technology
Technology
Biology
Biology
Biotechnology
Biotechnology
Location
Washington, D.C.
Washington, D.C.
0
Washington (state)
Washington (state)
0
Yeongdeungpo District
Yeongdeungpo District
0
South Korea
South Korea
Seoul
Seoul
0
B2X
B2B
B2B
Pitchbook URL
pitchbook.com/profiles...165063-97
Legal Name
GeneOne Life Science Inc.0
Subsidiary
VGXI
VGXI
Legal classification
Joint-stock company
Joint-stock company
Number of Employees (Ranges)
51 – 200
Email Address
genels@genels.com0
Phone Number
+161070756710
+18260043450
+822345840300
Full Address
The Pinnacle Gangnam, 10th Floor 343, Hakdong-Ro Gangnam-gu, Seoul 06060, South Korea
Parc.1 NH Finance Tower (Tower 2), 20th floor, 108 Yeoui-Daero, Yeongdeungpo-Gu, Seoul 07335, Korea0
535 Pennsylvania Ave, Suite 200, Fort Washington, PA190340
Founded Date
1976
0
Fax Number
+82-2-3458-40310
+1-610-707-56720
Business Model
Licensing
Stock Symbol
011000.KS0
Exchange
Korea Exchange
Korea Exchange
KOSPI Market
KOSPI Market
0
Patents Assigned (Count)
2
Headquarters
Seoul
Seoul
0

Other attributes

Company Operating Status
Active
Ticker Symbol
GENEONE

GeneOne Life Science Inc. is an international DNA vaccine and product developer, and leading contract manufacturer of DNA plasmid-based agents for pre-clinical and clinical trials for global companies and institutions. It researches and develops DNA vaccines and products to prevent and treat incurable diseases in South Korea and internationally. The company is headquartered in Seoul, South Korea. VGXI, Inc., GeneOne’s wholly-owned manufacturing subsidiary located in Texas.

COVID-19 Response

Houston Methodist researchers are partnering with GeneOne Life Science Inc. to develop an RNA vaccine against COVID-19, the novel coronavirus that has caused a global pandemic. Houston Methodist developed an RNA therapeutics research program to design, manufacture and test clinical-grade RNA.

Timeline

No Timeline data yet.

Funding Rounds

Products

Acquisitions

SBIR/STTR Awards

Patents

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more companies like GeneOne Life Science

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us